Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eye Tracking Technologies to Characterize and Optimize Visual Attending in Down Syndrome

NCT03764761 is registered in ClinicalTrials.gov with Penn State University as lead sponsor.

NCT NCT03764761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03764761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eye Tracking Technologies to Characterize and Optimize Visual Attending in Down Syndrome
Lead sponsor
Penn State University
Phase
Not applicable
Overall status
Terminated
Start date
April 1, 2018
Completion date
November 30, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

augmentative and alternative communication, down syndrome